PSA density adjusts your PSA level for prostate size. A high PSA density (≥0.15 ng/mL/cc) raises concern for cancer, especially when PSA seems borderline for your gland volume.
Prostate cancer is common in men over 50. Early detection through personalized screening improves treatment outcomes, especially for those with higher risk due to age, race, family history, or genetic factors.
Focal therapy offers targeted, minimally invasive prostate cancer treatment with functional benefits, but requires careful follow-up and lacks long-term data.
Prostate cancer screening enables early detection and more treatment options but carries risks like overdiagnosis and unnecessary interventions—individualized decisions based on personal risk and values are essential.
Prostate cancer screening should be personalized based on risk factors like age, race, family history, and BRCA mutations. High-risk men may need to begin screening as early as age 40–45.
The Miami Active Surveillance Trial (MAST) highlights the safety and structure of Active Surveillance (AS), offering evidence-based guidance for monitoring low-risk prostate cancer while preserving quality of life.
PI-RADS scores from prostate MRI indicate cancer risk; higher scores suggest biopsy. PSMA PET scans detect prostate cancer more accurately than CT or MRI, including spread to lymph nodes or bones.
Prostate cancer is classified as low, intermediate, or high risk based on Gleason score, PSA level, and tumor stage, guiding treatment from surveillance to combined therapies for aggressive cases.
PI-RADS is a 1–5 scoring system used in prostate MRI to assess cancer risk. Higher scores indicate higher likelihood of clinically significant prostate cancer and guide decisions about biopsy.
Prostate cancer screening includes PSA testing, MRI, biomarkers, and biopsy—each guiding diagnosis and decisions, with biopsy being the only definitive test but used selectively to avoid overtreatment.
Screening for Prostate Cancer
Understanding Prostate Biopsy
Pathology of Prostate Cancer
Treatment of Prostate CancerScreening for Prostate CancerUnderstanding Prostate BiopsyPathology of Prostate CancerTreatment of Prostate Cancer
